Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Sanchez

Showing results (191-200 of 319) with videos related to

Pageof 32
Sort By:
International Journal of Environmental Research and Public Health|November 13, 2021
Prevalence of Intimate Partner Violence, Substance Use Disorders and Depression among Incarcerated Women in Lima, PerúElena Cyrus, Jorge Sanchez, Purnima Madhivanan, et al.
Biotechnology and Applied Biochemistry|June 3, 2010
Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response inductionGillian Martínez-Donato, Alexis Musacchio, Liz Alvarez-Lajonchere, et al.
AIDS and Behavior|January 1, 2021
TransPrEP: Results from the Pilot Study of a Social Network-Based Intervention to Support PrEP Adherence Among Transgender Women in Lima, PeruJesse Clark, Sari Reisner, Amaya Perez-Brumer, et al.
Open Forum Infectious Diseases|May 25, 2022
Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance UseTrupti Gilada, Samuel R Schnittman, Edward White, et al.
Lancet (London, England)|July 19, 2016
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosisJosiah D Rich, Curt G Beckwith, Alexandria Macmadu, et al.
Stem Cells (Dayton, Ohio)|December 15, 2007
Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarctionCarolina Gandia, Ana Armiñan, Jose Manuel García-Verdugo, et al.
The Lancet. Rheumatology|May 10, 2026
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trialEric F Morand, Victoria P Werth, Joerg Wenzel, et al.
Urology|December 28, 2020
Simple Nephrectomy in a Tertiary Care Safety Net Hospital-Patient Characteristics, Causes, Cost, and Renal Function ImplicationsKyle S Ames, Fady Baky, Somer Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2010
Neurotoxic lupus autoantibodies alter brain function through two distinct mechanismsThomas W Faust, Eric H Chang, Czeslawa Kowal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 29, 2020
Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical StudyJavier R Lama, Rachel A Bender Ignacio, Ricardo Alfaro, et al.
Pageof 32

Showing results (191-200 of 319) with videos related to

Sort By:
Pageof 32
International Journal of Environmental Research and Public Health|November 13, 2021
Prevalence of Intimate Partner Violence, Substance Use Disorders and Depression among Incarcerated Women in Lima, PerúElena Cyrus, Jorge Sanchez, Purnima Madhivanan, et al.
Biotechnology and Applied Biochemistry|June 3, 2010
Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response inductionGillian Martínez-Donato, Alexis Musacchio, Liz Alvarez-Lajonchere, et al.
AIDS and Behavior|January 1, 2021
TransPrEP: Results from the Pilot Study of a Social Network-Based Intervention to Support PrEP Adherence Among Transgender Women in Lima, PeruJesse Clark, Sari Reisner, Amaya Perez-Brumer, et al.
Open Forum Infectious Diseases|May 25, 2022
Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance UseTrupti Gilada, Samuel R Schnittman, Edward White, et al.
Lancet (London, England)|July 19, 2016
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosisJosiah D Rich, Curt G Beckwith, Alexandria Macmadu, et al.
Stem Cells (Dayton, Ohio)|December 15, 2007
Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarctionCarolina Gandia, Ana Armiñan, Jose Manuel García-Verdugo, et al.
The Lancet. Rheumatology|May 10, 2026
Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trialEric F Morand, Victoria P Werth, Joerg Wenzel, et al.
Urology|December 28, 2020
Simple Nephrectomy in a Tertiary Care Safety Net Hospital-Patient Characteristics, Causes, Cost, and Renal Function ImplicationsKyle S Ames, Fady Baky, Somer Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2010
Neurotoxic lupus autoantibodies alter brain function through two distinct mechanismsThomas W Faust, Eric H Chang, Czeslawa Kowal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 29, 2020
Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical StudyJavier R Lama, Rachel A Bender Ignacio, Ricardo Alfaro, et al.
Pageof 32